DS Healthcare Group (NASDAQ: DSKX) is a developer of biotechnology for topical therapies and built a portfolio of personal care products and additional innovations in pharmaceutical projects. The company sells through a network of major domestic salons and spas, specialty retail channels and through distributors worldwide including Japan, Mexico, Brazil, Australia, Canada, China, throughout Europe and Asia. DS Healthcare’s strategy is to capitalize on opportunities to increase revenue, market share, and profitability in partnership with a worldwide distribution network. For more information, visit the company’s website at www.dslaboratories.com